Clinical Trial Update: Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic Rhinitis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing epinastine with sustained-release pseudoephedrine versus epinastine alone in patients with perennial allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• Epinastine (epinastine)
• Pseudoephedrine SR (pseudoephedrine sustained-release)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Rhinitis, Allergic, Perennial | Phase 3 | Status: COMPLETED